Webinar: What is the role of calprotectin in COVID-19
12. Apr 2021 |
5 min read
The role of calprotectin in COVID-19
Clinical studies report increased levels of calprotectin in patients with severe SARS-CoV-2 infection, as well as identifying the ability of calprotectin to differentiate between mild and severe forms of the disease and its capability to predict the need for mechanical ventilation and mortality1-6. This is valuable information that can help hospitals to better allocate essential resources that are often in limited supply.
In this webinar Gentian's VP Clinical Affairs Dr Aleksandra Havelka will give an introduction to the biomarker calprotectin in relation to severe COVID-19 and the hyper-inflammatory response, before she will go through several clinical studies discussing the value of calprotectin in COVID-19.
GCAL® - Gentian's calprotectin immunoassay - early access to results
Gentian’s Calprotectin Immunoassay GCAL®is a Particle-Enhanced Turbidimetric Immunoassay (PETIA), and is therefore rapidly performed in only 10 minutes, making it extra beneficial when it is critical to get fast access to the results.
Learn more about GCAL® - contact us now
Do you have questions about GCAL® or calprotectin's role in COVID-19 send an email firstname.lastname@example.org fill out the form below: